Get started
Apotea ABApotea ABApotea AB

Apotea AB

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFs
Full chart
Full chart

Compare with Apotea AB



Key stats


Market capitalization
‪8.27 B‬ SEK
Dividend yield (indicated)
0.79%
Price to earnings Ratio (TTM)
32.25
Basic EPS (TTM)
2.35 SEK
Net income (FY)
‪228.70 M‬ SEK
Revenue (FY)
‪7.20 B‬ SEK
Shares float
‪44.36 M‬
Beta (1Y)
0.63

Latest earnings


Last report date
Jul 17, 2026
Report period
Q2 2026
EPS
0.78 SEK
Earnings call summary

Q2 delivered strong revenue growth and profitability, driven by operational efficiency and the launch of apotea.no in Norway. Inventory and CapEx rose with the Varberg center, but the balance sheet remains robust. Growth initiatives and Rx expansion are key priorities.

Employees


Employees (FY)
969
Revenue / Employee (1Y)
‪7.43 M‬ SEK
Net income / Employee (1Y)
‪236.02 K‬ SEK

Details


Sector
Retail Trade
Industry
Specialty Stores
CEO
Pär Johan Svärdson
Website
apotea.se
Headquarters
Stockholm
Founded
2003
IPO date
Dec 6, 2024
ISIN
SE0023313762
FIGI
BBG01R0WBNP8
Identifiers
ISIN SE0023313762
CFI code
ESVUFR
Apotea AB engages in the provision of an online pharmacy that sells a range of both non-prescription and prescription drugs. It offers medicine for allergy, face, animal, fever and pain, cold, parent and child, aids and accessories, skin and hair, health food, hands and feet, stomach and intestine, mouth and teeth, travel packaging, stop smoking, wound, training and weight, vitamins and minerals, and eye and ear. The company was founded by Marie-Louise Jansson, Pär Johan Svärdson, and Susanne Söderberg in 2003 and is headquartered in Stockholm, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


AVDV
Avantis International Small Cap Value ETF
Weight0.03%
Market value‪4.78 M‬
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight0.03%
Market value‪981.74 K‬
IBUY
Amplify Online Retail ETF
Weight0.63%
Market value‪698.59 K‬
AVSV.USD
Avantis Global Small Cap Value UCITS ETF Accum I USD
Weight0.02%
Market value‪312.35 K‬
AVWS
American Century ICAV - Avantis Global Small Cap Value UCITS ETF AccumUSD
Weight0.02%
Market value‪312.35 K‬
DGTL
iShares Digitalisation UCITS ETF
Weight0.02%
Market value‪177.34 K‬
ZPRX
SSgA SPDR ETFs Europe II PLC - State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF Accum Ptg EUR
Weight0.02%
Market value‪127.22 K‬
SMC
SSgA SPDR ETFs EUROPE II PLC - State Street SPDR MSCI Europe Small Cap UCITS ETF
Weight0.04%
Market value‪118.72 K‬
IEUS
iShares MSCI Europe Small-Cap ETF
Weight0.03%
Market value‪50.59 K‬
EDOC
Global X Telemedicine & Digital Health UCITS ETF Accum Shs USD
Weight0.43%
Market value‪29.47 K‬
EDOG
Global X Telemedicine & Digital Health UCITS ETF USD
Weight0.43%
Market value‪29.47 K‬

Explore more ETFs 

Frequently asked questions


The current price of APOTEA is 74.25 SEK — it has decreased by −0.13% in the past 24 hours. Watch Apotea AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange Apotea AB stocks are traded under the ticker APOTEA.
APOTEA stock has risen by 0.86% compared to the previous week, the month change is a 2.64% rise, over the last year Apotea AB has showed a −31.29% decrease.
We've gathered analysts' opinions on Apotea AB future price: according to them, APOTEA price has a max estimate of 100.00 SEK and a min estimate of 79.00 SEK. Watch APOTEA chart and read a more detailed Apotea AB stock forecast: see what analysts think of Apotea AB and suggest that you do with its stocks.
APOTEA reached its all-time high on Jul 28, 2025 with the price of 122.00 SEK, and its all-time low was 54.40 SEK and was reached on Mar 19, 2026. View more price dynamics on APOTEA chart.
See other stocks reaching their highest and lowest prices.
APOTEA stock is 2.77% volatile and has beta coefficient of 0.63. Track Apotea AB stock price on the chart and check out the list of the most volatile stocks — is Apotea AB there?
Today Apotea AB has the market capitalization of ‪7.90 B‬, it has increased by 5.58% over the last week.
Yes, you can track Apotea AB financials in yearly and quarterly reports right on TradingView.
Apotea AB is going to release the next earnings report on Nov 5, 2026. Keep track of upcoming events with our Earnings Calendar.
APOTEA earnings for the last quarter are 0.78 SEK per share, whereas the estimation was 0.71 SEK resulting in a 9.86% surprise. The estimated earnings for the next quarter are 0.70 SEK per share. See more details about Apotea AB earnings.
Apotea AB revenue for the last quarter amounts to ‪2.03 B‬ SEK, despite the estimated figure of ‪2.01 B‬ SEK. In the next quarter, revenue is expected to reach ‪1.99 B‬ SEK.
APOTEA net income for the last quarter is ‪81.40 M‬ SEK, while the quarter before that showed ‪79.20 M‬ SEK of net income which accounts for 0.00% change. Track more Apotea AB financial stats to get the full picture.
Yes, APOTEA dividends are paid annually. The last dividend per share was 0.60 SEK. As of today, Dividend Yield (TTM)% is 0.79%. Tracking Apotea AB dividends might help you take more informed decisions.
Apotea AB dividend yield was 0.65% in 2025, and payout ratio reached 27.30%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 22, 2026, the company has 969 employees. See our rating of the largest employees — is Apotea AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Apotea AB EBITDA is ‪502.20 M‬ SEK, and current EBITDA margin is 6.38%. See more stats in Apotea AB financial statements.
Like other stocks, APOTEA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apotea AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Apotea AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Apotea AB stock shows the sell signal. See more of Apotea AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.